Group 1 - The core viewpoint emphasizes the need for government and corporate collaboration to advance robot technology in healthcare, addressing current technical and ethical challenges to achieve an ideal "human-robot collaboration" care model [1][9] - Japan's aging population has led to a surge in elderly care demand, with a projected market size of approximately $5 billion for humanoid medical care robots by 2030, growing at an annual rate of about 15% [1][9] - The Japanese government has heavily invested in the development of robots for the healthcare sector, launching the "Robot New Strategy" in 2013 and designating 24 companies for subsidies totaling 2.39 billion yen to support the development of care robots [2][9] Group 2 - Toyota's HSR robot, designed for elderly care and assisting disabled individuals, is equipped with features like wheeled movement and voice interaction, but lacks a full humanoid appearance and has no set timeline for mass production [3][9] - The high costs of robot production have led to the discontinuation of several notable robots, such as Honda's ASIMO and RIKEN's Robear, which faced challenges in achieving commercial viability due to their expensive price tags and limited practical applications [4][5] - The Japanese robot manufacturing industry is facing challenges, including high production costs and limited practical utility, which hinder the commercialization and scalability of humanoid robots in the healthcare sector [7][9] Group 3 - The healthcare robot market in Japan is expected to reach approximately 7.2 trillion yen (about 357 billion yuan) by 2025, with care robots identified as a key growth area to address the aging population [7] - The lack of competitiveness in AI development has contributed to Japan's struggles in the robot manufacturing sector, as the country has not produced AI companies comparable to global leaders [8] - The practical applications of humanoid robots in healthcare have been recognized, particularly in enhancing emotional support, physical assistance, and daily living aid, with expectations for widespread adoption by 2030 as technology matures and costs decrease [9]